AIR340B is dedicated to reforming the 340B program to ensure large hospitals are not profiting at the expense of vulnerable patients, taxpayers & employers.
Did you know you’re paying a hidden tax because of #340B? The 340B program allows big hospitals to purchase medications at deeply discounted rates and mark up the price drastically, raising costs for patients, taxpayers, employers and the government. Learn more about how 340B is being misused and costing all of us below ⬇️
💵 PBMs and for-profit pharmacy chains dominate the #340B contract pharmacy market, with the five largest companies accounting for over 75% of all relationships. Transparency is needed to ensure this program designed for patients isn’t exploited by multi-billion-dollar companies. Learn more in @DrugChannels: https://t.co/IaYAaGSSJk
“The 340B program remains a well-intentioned policy built on a flawed incentive structure.” – @HEALntwk Stephen Parente explains how #340B leaves hospitals pocketing the spread of program discounts with no transparency in place. Reform is long overdue. Read more in @TheWellNews: https://t.co/VbrDlr9kb0
In 340B, tax-exempt hospital systems buy discounted drugs, mark them up by as much as 1,000% or more and bill patients and insurers the list price.
$80 billion+ every year and growing
TY @RepMGriffith for focusing on affordability
@C4AHC
https://t.co/hUPEPxXkeR via @cardinalnewsva
50% of U.S. patients with cancer rely on #CommunityOncology. We must restore competition, lower costs, and ensure access for those relying on local clinics. Policymakers need to stop harmful consolidation, fix #PBMs, and reform 340B. Our recommendations: https://t.co/edL2L8Q3Wm
“When a law intended to help patients afford their drugs is funneling money into the pockets of hospitals and never reaches those patients, the law needs reform.” – @ncl_tweets@sallygreenberg calls on the need for federal reform as patients and taxpayers face high costs from #340B. Read more in @CrainsChicago: https://t.co/yBUSCFefeA
The #340B program diverts funds intended for patients, consolidates private practices and creates a hidden tax on us all. In a @CTMirror opinion, Connecticut Oncology Association Dawn Holcombe calls attention to the out-of-control abuse of the 340B program: https://t.co/ZKPCVTb3wC
The report, The 340B Program Impact on Rural Hospitals, reveals stark disparities between rural and non-rural hospitals and raises concerns about policy and structural challenges that threaten the stability of rural healthcare systems.
https://t.co/eEe14vY1lE
NEW! In @CardinalNewsVA, learn more from @HarryGewanter about how #340B has run off course and drives up costs for families in VA. @RepMGriffith is right to demand answers and hold hospitals accountable for how billions in 340B savings are being used. ➡️ https://t.co/Akd1rbPbBW
Dr. Robert Popovian of @GHLForg on #340BReform: “Hospitals taking in hundreds of millions of dollars, if not billions, in #340B-related revenue, should have to show how that money is actually helping patients.”
https://t.co/oYbPQaRkr5
Congress created 340B to help vulnerable patients -- not to pad hospital bottom lines. As this new @Forbes piece explains, the program has exploded into a multibillion-dollar system with little transparency or accountability. Reform is long overdue. https://t.co/MFL7HqsOy9
Congress is right to take a closer look at the 340B program and the hidden costs it creates for patients, families, employers, and taxpayers. Thank you to @RepMGriffith for leading oversight efforts and pushing for commonsense 340B reform. More here: https://t.co/IK6xCU1vrn
NEW: AIR340B member @NationalGrange released a report confirming large #340B hospital systems divert funds away from rural communities, with nearly 97% of drug claims occurring in urban hospitals. Commonsense solutions are needed to ensure #340B helps vulnerable patients as intended. See more: https://t.co/HJDZjm89oP
Carveouts in a #340B rebate model risk enabling health system middlemen to siphon more dollars out of a program meant to benefit patients. Read more from Dr. Neal Masia in @MHExecutive about how 340B is not operating as intended: https://t.co/9OMvn7TeuE
Check out a @CardinalNewsVA opinion from CSRO board member @HarryGewanter on how the #340B program is raising health care costs and incentivizing consolidation. He applauds @RepMGriffith for advocating for much-needed 340B transparency and accountability: https://t.co/LSY7b2O0JJ
The Wall Street Journal editorial board is confirming what we know about #340B: some of the wealthiest hospitals use loopholes to obtain discounts for their own investments and acquisitions instead of directly helping patients.
Read more via @WSJ >> https://t.co/OEmtofHTJG
“Employers have a real stake in how 340B operates and should have a seat at the table.” – National Alliance of Healthcare Purchaser Coalitions @sgremminger highlights how employers are burdened by #340B abuse, as the current structure leaves purchasers to foot the bill of program revenue. Read more in @Daily_Press: https://t.co/anwA64p1s9
🧑⚕️Dr. @HarryGewanter, board member of AIR340B member @CSROAdvocacy, applauds @RepMGriffith for questioning how large hospital systems are using #340B savings. His efforts reflect growing momentum in Congress to improve 340B program transparency. Read more in @CardinalNewsVA: https://t.co/4ryDxrjrtN
Misaligned incentives in the #340B program come at a detriment to taxpayers as tax-exempt 340B hospitals pocket savings intended for patients. Read more in @Townhall.com: https://t.co/3IngMImbe7
In an @IdahoStatesman opinion, retired surgeon Dr. Roger Stark highlights how the #340B program has ballooned in size, driving costs for patients, taxpayers and employers. He urges for a 340B rebate pilot program to improve program accountability. Read more: https://t.co/DRRA4hqRZJ